Situation Awareness: Cautious. Semiconductors staged a rebound after seven ugly sessions, lifting the Nasdaq (+0.66% to 26,172.34) ahead of the S&P 500 (+0.32% to 7,677.28) and the Dow (+0.30% to 53,577.40), with NVDA (+2.14% to $212.95) breaking its losing streak just ahead of Wednesday’s after-close earnings; note SPY/QQQ/IWM ETF prices and their 200-day levels are unavailable in today’s data so we lean on index cash levels. Trade mode for tomorrow: selective and defensive — let the PCE print and NVDA reaction set the tone before committing size. The tape was driven by a narrow chip snapback (SOX +1.4%) against soft retail and a 3.2% oil slide, so leadership was thin rather than broad. Regime context — 51.9% of stocks closed above their 40-day SMA (vs 54.4% prior day, regime held at Cautious), and the 4% Bull/Bear gauge shows 202 bulls vs. 56 bears. The 5-day trend is choppy and two-sided, with breadth actually slipping day-over-day even as indexes rose — a divergence that signals narrowing participation.
SIP: NVDA SMCI MRNA HOOD
- What’s working: Continuation (2LYNCH) fired 19 signals, D9M 11 signals, 9M Catalyst 1 (HOOD), Reversal Bullish 5, Darvas Box 25 — momentum breakouts and biotech pivots led.
- Leading sectors: Basic Materials +1.49%, Healthcare +1.09%, Communication Services +0.98%; leading themes: Cannabis +10.42%, Generic Drugs +8.51%, Crypto/Blockchain +3.85%.
- Key event: Dick’s Sporting Goods (DKS -30.68%) cratered on weak Foot Locker results, dragging NKE, DECK and LULU and gutting the athletic-apparel complex.
- Regime threading: morning SA called Cautious (54.4%), closing is Cautious (51.9%) — held, but the breadth erosion under a green tape keeps us defensive.
- DEP watchlist: HOOD, SMCI, UUUU, IBRX, SE — strongest D9M setups into tomorrow.
- SIPS: KYMR, SE, CDW — top Continuation swing candidates.
Market Scorecard
- SPY/QQQ/IWM ETF data unavailable in today’s feed — using cash indexes: S&P 500 +0.32% (7,677.28), Nasdaq +0.66% (26,172.34), Dow +0.30% (53,577.40).
- Breadth final: 51.86% above 40-SMA (down 2.6pp) and 56% above 20-SMA (down 6.0pp) — a bearish divergence as breadth fell while indexes rose.
- Volume context: NYSE 1.00 bln, Nasdaq 7.53 bln; advancers led (NYSE 1577/1136, Nasdaq 3166/1770) but the narrow chip-driven leadership reads more like selective accumulation than broad conviction.
Today’s Scorecard — What Worked & What Didn’t
- Winners — semis/AI: SMCI +9.33% ($38.45) on Cisco’s expanded NVIDIA partnership, NVDA +2.14%, SOX +1.4% lifting Info Tech +1.0%.
- Second theme — healthcare/biotech: MRNA +14.36% ($158.83) rebounding on melanoma vaccine momentum, plus Cannabis (+10.42%) and Generic Drugs (+8.51%) running.
- What failed — retail/apparel: DKS -30.68%, NKE -3.13%, DECK -3.63%, LULU -3.62%; energy sank -1.7% as WTI fell 3.2% to $82.29.
- Breadth trend: 51.9% above 40-SMA with a choppy 5-day sequence and Bull 4% collapsing to 202 from a healthier 133-vs-232 flip yesterday — participation is thinning.
Key Earnings & Economic Calendar
- Today’s mover: DKS (-30.68%) delivered the session’s ugliest single-stock reaction on soft Foot Locker results, poisoning apparel sentiment.
- Second report: Gorilla Technology (GRRR) posted 1H26 revenue +99.3% and raised FY26 guidance but guided FY27 below consensus.
- Tomorrow’s data (Wednesday): July Personal Income & Outlays with the Fed-preferred PCE gauge, plus the Q2 GDP second estimate (expected to hold at 1.5%); also a $70 bln 5-year note auction.
- Tomorrow’s key earnings: NVIDIA (NVDA) reports after the close — the single biggest catalyst of the week for the AI trade and index direction.
Tomorrow’s Watchlist & Setups
- NVDA at $212.95 — post-earnings catalyst play; do not pre-position size, trade the reaction as it either confirms or breaks the chip rebound.
- SMCI at $38.46 — Continuation/EG100 setup sitting at demand ($33.94–$37.61); breakout trigger over $40.64 supply, tightly tied to NVDA‘s print.
- HOOD at $112.07 — 9M Catalyst leader on crypto-rally tailwind; at supply near $114.88–$116.43, needs a clean push through to extend, risk is elevated.
- MRNA at $158.83 — Darvas Box with wide 12.5% ATR; high volatility, only for reduced size on continuation above today’s range.
- Sector focus: Healthcare/Basic Materials — best breadth (605↑ and 166↑) and constructive momentum while retail and energy stay avoid-lists.
Strategy Outlook & Scenarios
- Bullish scenario: a strong NVDA print plus an in-line/cool PCE reopens broad participation — watch for pct_above_40SMA reclaiming 55%+ and the S&P holding above 7,650.
- Bearish scenario: a hot PCE or NVDA disappointment cracks the chip rebound; a drop under 45% on the 40-SMA breadth and a failed 7,600 hold would downgrade the regime toward Cautious Bearish.
- Signal counts: 2LYNCH 19, D9M 11, Reversal 5, Darvas 25 — momentum scans remain active but breadth deteriorated day-over-day, a caution flag.
- Tomorrow’s regime forecast: Cautious — event-driven (PCE + NVDA) with thinning breadth argues for patience over aggression.
Action Codes
- CRT (Controlled Risk Taking): Cautious regime with an event-heavy tape demands trimmed size and defined stops into PCE and NVDA.
- T3A (Think 3 Days Ahead): Position around Wednesday’s PCE-plus-NVDA double catalyst rather than chasing today’s narrow chip bounce.
Summary & Final Thoughts
- Game plan: stay patient into the PCE report and NVDA earnings, then trade the confirmed reaction in semis and healthcare leaders.
- Key risk: green indexes masked falling breadth (56% to 51.9% above 20/40-SMA) — a narrow chip rally can reverse fast if NVDA stumbles.
- Overall stance: selective and defensive — respect the Cautious regime, keep risk controlled, and let Wednesday’s catalysts do the work.